Nephropathy in patients with type 2 diabetes mellitus, N. Engl. J. Med, vol.341, pp.1127-1133, 1999. ,
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease, Nat. Rev. Nephrol, vol.12, pp.73-81, 2016. ,
Update on Diabetic Nephropathy: Core Curriculum, Am. J. Kidney Dis, vol.71, pp.884-895, 2018. ,
Renal endothelial dysfunction in diabetic nephropathy, Cardiovasc. Hematol. Disord. Drug Targets, vol.14, pp.22-33, 2014. ,
Endothelium structure and function in kidney health and disease, Nat. Rev. Nephrol, vol.15, pp.87-108, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02160201
Glomerular endothelial cell fenestrations: An integral component of the glomerular filtration barrier, Am. J. Physiol. Ren. Physiol, vol.296, pp.947-956, 2009. ,
The role of the glomerular endothelium in albumin handling, Nat. Rev. Nephrol, vol.9, pp.717-725, 2013. ,
The glycocalyx-Linking albuminuria with renal and cardiovascular disease, Nat. Rev. Nephrol, vol.11, pp.667-676, 2015. ,
The endothelium in diabetic nephropathy, Curr. Atheroscler. Rep, vol.16, p.410, 2014. ,
Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy, Kidney Int, vol.82, pp.1010-1017, 2012. ,
Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability, Acta Physiol, vol.204, pp.294-307, 2012. ,
Pathologic classification of diabetic nephropathy, J. Am. Soc. Nephrol, vol.21, pp.556-563, 2010. ,
Pathology of human diabetic nephropathy, Contrib. Nephrol, vol.170, pp.36-47, 2011. ,
Differential glucose uptake in retina-and brain-derived endothelial cells, Microvasc. Res, vol.62, pp.236-242, 2001. ,
Delayed autoregulation of glucose transport in vascular endothelial cells, Diabetologia, vol.48, pp.752-755, 2005. ,
Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies, Diabetes Metab, vol.36, pp.1-10, 2010. ,
Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice, Kidney Int, vol.82, pp.1176-1183, 2012. ,
Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension, Diabetes, vol.52, pp.512-518, 2003. ,
High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: Role of protein kinase C and reactive oxygen species, Circulation, vol.107, pp.1017-1023, 2003. ,
The locally activated renin-angiotensin system is involved in albumin permeability in glomerular endothelial cells under high glucose conditions, Nephrol. Dial. Transplant, vol.32, pp.61-72, 2017. ,
Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells, Kidney Int, vol.96, pp.957-970, 2019. ,
High glucose causes dysfunction of the human glomerular endothelial glycocalyx, Am. J. Physiol. Ren. Physiol, vol.300, pp.40-48, 2011. ,
Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy, Diabetologia, vol.38, pp.2100-2108, 1995. ,
Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species, Nephrol. Dial. Transplant, vol.24, pp.2637-2645, 2009. ,
The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-?B signaling pathway, Mol. Cell. Endocrinol, vol.470, pp.14-25, 2017. ,
Heparanase is essential for the development of diabetic nephropathy in mice, Diabetes, vol.61, pp.208-216, 2012. ,
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy, J. Am. Soc. Nephrol, vol.23, pp.123-130, 2012. ,
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: A randomized controlled trial, Am. J. Kidney Dis, vol.58, pp.729-736, 2011. ,
LY333531, a PKC? inhibitor, attenuates glomerular endothelial cell apoptosis in the early stage of mouse diabetic nephropathy via down-regulating swiprosin-1, Acta Pharmacol. Sin, vol.38, pp.1009-1023, 2017. ,
High glucose induces activation of the local reninangiotensin system in glomerular endothelial cells, Mol. Med. Rep, vol.9, pp.450-456, 2014. ,
Gene expression profiles of glomerular endothelial cells support their role in the glomerulopathy of diabetic mice, Kidney Int, vol.94, pp.326-345, 2018. ,
High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3, Circulation, vol.101, pp.2618-2624, 2000. ,
VEGF and the diabetic kidney: More than too much of a good thing, J. Diabetes Complicat, vol.31, pp.273-279, 2017. ,
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man, Kidney Int, vol.69, pp.1654-1661, 2006. ,
BAMBI elimination enhances alternative TGF-? signaling and glomerular dysfunction in diabetic mice, Diabetes, vol.64, pp.2220-2233, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01850503
Central role of dysregulation of TGF-?/Smad in CKD progression and potential targets of its treatment, Biomed. Pharmacother, vol.101, pp.670-681, 2018. ,
, The connecting link between nephropathy and fibrosis, vol.38, pp.39-49, 2016.
Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition, J. Am. Soc. Nephrol, vol.19, pp.2282-2287, 2008. ,
Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice, Am. J. Pathol, vol.175, pp.1380-1388, 2009. ,
Transforming growth factor beta (TGF?) and related molecules in chronic kidney disease (CKD), Clin. Sci, vol.133, pp.287-313, 2019. ,
Anti-TGF-?1 Antibody Therapy in Patients with Diabetic Nephropathy, J. Am. Soc. Nephrol, vol.28, pp.953-962, 2017. ,
Diabetes and Kidney Disease: Role of Oxidative Stress, Antioxid. Redox Signal, vol.25, pp.657-684, 2016. ,
Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production, J. Am. Soc. Nephrol, vol.18, pp.2945-2952, 2007. ,
Human glomerular endothelium: Interplay among glucose, free fatty acids, angiotensin II, and oxidative stress, Am. J. Physiol. Ren. Physiol, vol.298, pp.125-132, 2010. ,
Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes, Nephrol. Dial. Transplant, vol.24, pp.1884-1888, 2009. ,
Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney, Diabetes, vol.55, pp.1651-1659, 2006. ,
Diabetic nephropathy is resistant to oral l-arginine or l-citrulline supplementation, Am. J. Physiol. Ren. Physiol, vol.307, pp.1292-1301, 2014. ,
Role of oxidative stress in diabetes-mediated vascular dysfunction: Unifying hypothesis of diabetes revisited, Vasc. Pharmacol, vol.57, pp.139-149, 2012. ,
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage, Nature, vol.404, pp.787-790, 2000. ,
Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, reduced NO, and enhanced PGH(2)/TXA(2) mediation, Am. J. Physiol. Heart Circ. Physiol, vol.293, pp.3096-3104, 2007. ,
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE, Am. J. Physiol. Endocrinol. Metab, vol.280, pp.685-694, 2001. ,
Deterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats, Diabetologia, vol.53, pp.2056-2065, 2010. ,
Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility, vol.66, pp.763-778, 2017. ,
Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: Potential role in diabetic nephropathy, Diabetes, vol.52, pp.2570-2577, 2003. ,
Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney, Nephrology, vol.10, pp.7-10, 2005. ,
Vascular incompetence in dialysis patients-Protein-bound uremic toxins and endothelial dysfunction, Semin. Dial, vol.24, pp.327-337, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01610435
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes, Investig. Ophthalmol. Vis. Sci, vol.41, pp.1153-1158, 2000. ,
, Endothelial Progenitors: A Consensus Statement on Nomenclature. Stem Cells Transl. Med, vol.6, pp.1316-1320, 2017.
Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes, Pharmacol. Ther, vol.170, pp.98-115, 2017. ,
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes, Diabetes Care, vol.33, pp.1097-1102, 2010. ,
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures, Circulation, vol.106, pp.2781-2786, 2002. ,
High glucose-induced endothelial progenitor cell dysfunction, Diabetes Vasc. Dis. Res, vol.14, pp.381-394, 2017. ,
Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells, Investig. Ophthalmol. Vis. Sci, vol.52, pp.5093-5104, 2011. ,
Angiogenic dysfunction in bone marrow-derived early outgrowth cells from diabetic animals is attenuated by SIRT1 activation, Stem Cells Transl. Med, vol.1, pp.921-926, 2012. ,
Serum levels of advanced glycation end products (AGEs) are inversely associated with the number and migratory activity of circulating endothelial progenitor cells in apparently healthy subjects, Cardiovasc. Ther, vol.30, pp.249-254, 2012. ,
Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2, Biochem. Biophys. Res. Commun, vol.381, pp.192-197, 2009. ,
Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways, Biomed. Pharmacother, vol.64, pp.35-43, 2010. ,
Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells, Cardiovasc. Diabetol, vol.11, 2012. ,
Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: Implications for vasodegeneration in diabetic retinopathy, Investig. Ophthalmol. Vis. Sci, vol.49, pp.1232-1241, 2008. ,
, Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group, Kidney Int, vol.47, pp.1703-1720, 1995.
, DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up, Diabetes Control and Complications Trial, vol.39, pp.686-693, 2016.
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N. Engl. J. Med, vol.358, pp.2560-2572, 2008. ,
Nephroprotective Effects of Metformin in Diabetic Nephropathy, J. Cell. Physiol, vol.232, pp.731-742, 2017. ,
Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium, Acta Physiol, vol.219, pp.138-151, 2017. ,
Advanced glycation end products and nephrotoxicity of high-protein diets, Clin. J. Am. Soc. Nephrol, vol.1, pp.1293-1299, 2006. ,
Glomerular cell death and inflammation with high-protein diet and diabetes, Nephrol. Dial. Transplant, vol.28, pp.1711-1720, 2013. ,
Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update, Eur. J. Pharmacol, vol.791, pp.8-24, 2016. ,
Effects of folic acid on renal endothelial function in patients with diabetic nephropathy: Results from a randomized trial, Clin. Sci, vol.127, pp.499-505, 2014. ,
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis, PLoS ONE, vol.12, 2017. ,
SGLT2 inhibitors and the kidney: Effects and mechanisms, Diabetes Metab. Syndr, vol.12, pp.1117-1123, 2018. ,
SGLT2 Inhibitors Through the Windows of EMPA-REG and CANVAS Trials: A Review, vol.8, pp.1245-1251, 2017. ,
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups, Circulation, vol.140, pp.739-750, 2019. ,
Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA, Curr. Diabetes Rep, vol.18, p.45, 2018. ,
Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study, Cardiovasc. Diabetol, vol.16, 2017. ,
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats, Redox Biol, vol.13, pp.370-385, 2017. ,
The SGLT2 Inhibitor Luseogliflozin Rapidly Normalizes Aortic mRNA Levels of Inflammation-Related but Not Lipid-Metabolism-Related Genes and Suppresses Atherosclerosis in Diabetic ApoE KO Mice, Int. J. Mol. Sci, vol.18, 1704. ,
Angiotensin II-induced redox-sensitive SGLT1 and 2 expression promotes high glucose-induced endothelial cell senescence, J. Cell. Mol. Med, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02322649
Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis, Diabetes Vasc. Dis. Res, vol.15, pp.64-73, 2018. ,
Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): A randomised, double-blind, placebo-controlled trial, Lancet Diabetes Endocrinol, vol.7, pp.429-441, 2019. ,
Interactions of DPP-4 and integrin ?1 influences endothelial-to-mesenchymal transition, Kidney Int, vol.88, pp.479-489, 2015. ,
Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism, PLoS ONE, vol.9, 2014. ,
Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A, Arterioscler. Thromb. Vasc. Biol, vol.30, pp.1407-1414, 2010. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2019 by the authors. Licensee MDPI